HealthTech Integrates 2023 Track 1
PROMISE
HealthTech is an integral part of today’s healthcare, how do we ensure delivery of the benefits it offers?
Welcome and opening remarks
NEIL MESHER | Senior Vice President | Philips, Western Europe
Fireside Chat
Fireside Chat 1
Steven Roberts | Chief Scientific Advisor | Barclays UK
Interviewed by
Jane Kennedy | Chief Business Officer | Discovery Park
Fireside Chat 2
Cristina Duran | Chief Digital Health Officer, R&D | AstraZeneca
Interviewed by
Paul Wicks | Independent Consultant | Wicks Digital Health
Lighting the way
With the advent of RWD, omics data, imaging data, Dx data etc, enabling prediction of disease progression following early diagnosis – can we begin to practice preventative medicine now rather than symptom treatment as we have been?
FACILITATED BY
Louise Jopling | Commercial Director | Eastern Academic Health Science Network
PANELLISTS INCLUDE
Debora Lucarelli | Chief Executive Officer | Enhanc3D Genomics
Anthony Finbow | Chief Executive Officer | Eagle Genomics
Jane Theaker | Chief Executive Officer | PBD Biotech
Ellie Halliday | Data Privacy & Compliance Manager | Talking Medicines
Cleaner future?
How does this industry embrace sustainability? Are we going to be able to move away from single-use plastics and enable recycling? Have we got the answer to the carbon costs of data processing and storage etc?
FACILITATED BY
Martin Baxter | Chief Executive Officer | IEMA
PANELLISTS INCLUDE
Addie MacGregor | Sustainability Executive | ABHI
Michelle Sullivan | Head Of Public Affairs | Boston Scientific
Daniel Coole | Managing Director | Surgical Holdings
Brennan Miles | Head of Drug Delivery | Team Consulting
Pete Waddingham | National NetZero Lead | The AHSN Network
Wear’s my data?
What actionable value can be achieved from wearables data? With multiple owners of these data in multiple formats – how can we join the dots on an individual patient level and enable better informed clinical decision making?
FACILITATED BY
Beverley Vaughan | Innovation Hubs Director | ARISE
PANELLISTS INCLUDE
Emilė Radytė | Co-founder & CEO | Samphire Neuroscience
Camille Carroll | Honorary Consultant Neurologist | Plymouth Hospitals NHS Trust
Nigel Brokenshire | Head of Digital Healthcare UK/I | Bayer PLC
Rahul Kapoor | Director of Health Tech | CPI
Luca Lipani | Co-Founder & Chief Executive Officer | Transdermal Diagnostics
Navigating the regulatory pathway
How do you prepare your regulatory strategy to enable a rapid route to market? US, EU, UK – selecting the right regulatory pathway?
FACILITATED BY
Hugh Harvey | Managing Director | Hardian Health
PANELLISTS INCLUDE
Vishal Thakker | Head of UK Approved Body & Senior Regulatory Lead | British Standards Institution (BSI)
Ema Kufel | Co-founder & UK Chief Executive Officer | Prosoma
Mina Frost | Founder & Director | Decode X
James Fry | Partner and Head of Life Sciences | Mills & Reeve
Ama Frimpong | Head of Product Development | 52 North Health
The brightest and the best
The need for Covid-19 testing saw an explosion in the molecular diagnostics arena and rapid adoption – How do we build on that success? (PCR and beyond – facilitating early infectious disease detection)
FACILITATED BY
Pari Datta | Principle Consultant – Strategy/Diagnostics & Life Sciences | Cambridge Design Partnership
PANELLISTS INCLUDE
John Tyson | Head of the North East Innovation Lab | Newcastle Upon Tyne Hospitals NHS Foundation Trust
Frederick Manduca | Director | Newfoundland Diagnostics
Jonathan O’Halloran | Chief Executive Officer | QuantuMDx Group
Peter Whawell | Chief Executive Officer | Proxximos
Robert Porter | Chief Executive Officer | RAPIvD